Thyroid-related laboratory abnormalities to predict treatment-limiting adverse events in melanoma patients treated with immune checkpoint blockade.

被引：2
|
作者：
Altman, Daniel
Weight, Ryan Michael
Shah, Mansi R.
Orloff, Marlana M.
Sharpe-Mills, Erin
Mastrangelo, Michael J.
Sato, Takami
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA USA
[2] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[3] Thomas Jefferson Univ, Dept Med Oncol, Kimmel Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e14536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14536
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors
    Sen, Gulin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Safarov, Shamkhal
    Guliyev, Murad
    Bedir, Sahin
    Can, Gunay
    Turna, Hande
    Ozguroglu, Mustafa
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [33] Incidence of thyroid immune-related adverse events in melanoma patients treated with pembrolizumab in an expanded access program
    Jeroen, de Filette
    Yanina, Jansen
    Max, Schreuer
    Hendrik, Everaert
    Brigitte, Velkeniers
    Bart, Neyns
    Bert, Bravenboer
    ACTA CLINICA BELGICA, 2016, 71 : 19 - 19
  • [34] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [35] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
  • [36] Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade
    Usmani, Abul
    Earland, Noah
    Zhang, Wubing
    Harris, Peter K.
    Bacchiocchi, Antonietta
    Nene, Aishwarya
    Chen, David Y.
    Sznol, Mario
    Halaban, Ruth
    Newman, Aaron M.
    Chaudhuri, Aadel A.
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.
    Gandhi, Aesha
    Taylor, John
    Morici, Michael
    Reid, Anna
    Meniawy, Tarek
    Khattak, Muhammad Adnan
    Gray, Elin
    Millward, Michael
    Zaenker, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] CYTOKINE CHANGES DURING IMMUNE-RELATED ADVERSE EVENTS AND STEROID TREATMENT IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Tyan, Kevin
    Baginska, Joanna
    Brainard, Martha
    Giobbie-Hurder, Anita
    Severgnini, Mariano
    Manos, Michael
    Haq, Rizwan
    Buchbinder, Elizabeth
    Ott, Patrick
    Hodi, F. Stephen
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A389 - A390
  • [39] Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
    Tyan, Kevin
    Baginska, Joanna
    Brainard, Martha
    Giobbie-Hurder, Anita
    Severgnini, Mariano
    Manos, Michael
    Haq, Rizwan
    Buchbinder, Elizabeth I.
    Ott, Patrick A.
    Hodi, F. Stephen
    Rahma, Osama E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2209 - 2221
  • [40] Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
    Kevin Tyan
    Joanna Baginska
    Martha Brainard
    Anita Giobbie-Hurder
    Mariano Severgnini
    Michael Manos
    Rizwan Haq
    Elizabeth I. Buchbinder
    Patrick A. Ott
    F. Stephen Hodi
    Osama E. Rahma
    Cancer Immunology, Immunotherapy, 2021, 70 : 2209 - 2221
12345